Fasting Plus Morning Window Matches Dieting for Loss, Diverges on Appetite Control

TL;DR: Fasting and daily dieting lost similar weight, but changed eating behaviour differently

Both intermittent fasting plus early time-restricted eating and daily calorie restriction produced greater weight loss than standard care at 2 and 6 months, while only calorie restriction produced larger sustained increases in dietary restraint and larger reductions in disinhibition and hunger, with reduced disinhibition explaining 15% of the calorie-restriction weight-loss effect, according to the study published on 15 May 2026 in Clinical Nutrition.

The report titled “Exploring the impact of intermittent fasting plus time-restricted eating versus calorie restriction on eating behavior, mood, sleep, quality of life in adults with obesity” compared psychological and behavioural responses after 6 months and 18 months. The authors stated that psychological and behavioural effects influence diet adherence and mediate the effectiveness of lifestyle interventions but are poorly studied with intermittent fasting approaches. The trial is registered as NCT03689608. Funding was provided by the National Health and Medical Research Council for research described as intermittent fasting versus daily energy restriction for improved human health.

Study examined fasting with a morning eating window against daily restriction

The trial randomized adults with obesity to one of three groups in a 2:2:1 ratio. One group followed intermittent fasting plus early time-restricted eating, termed iTRE. A second group followed calorie restriction, termed CR. A third group received standard care, termed SC.

The iTRE prescription was 30% of energy requirements between 8am and 12pm followed by 20-hour fasting on three non-consecutive days, with non-restricted intake on the other days. The CR prescription was 70% of energy requirements. The SC group was provided healthy guidelines at baseline only. Both the iTRE and CR groups received nutritional support biweekly. Eating behaviours, mood, sleep and quality of life were assessed using validated questionnaires at month 0, 2, 6 and 18.

Who took part and how long they were followed

Reporting on the trial by Foodinnov described 209 adults with obesity with a mean age of 58 years and elevated risk of type 2 diabetes. The intervention period described in that report was six months, with assessments at the start of the trial and then after 2 months, 6 months and 18 months of follow-up. The same report noted that the iTRE group consumed only 30% of energy needs between 8h and noon, followed by a 20-hour fast, on three non-consecutive days per week, and could eat normally on the other days. It described the second group as following classic daily calorie restriction with a daily 30% reduction in energy intake. It described the third group as receiving only standard nutritional recommendations without specific support.

The authors listed for the Clinical Nutrition paper are Xiao Tong Teong, Kai Liu, Andrew D. Vincent, Bo Liu, Gary Wittert, Amy T. Hutchison and colleagues, with Leonie Kaye Heilbronn as corresponding author. The listed affiliations include the South Australian Health and Medical Research Institute and Adelaide University. The publication date given for the Clinical Nutrition paper is 15 May 2026.

Weight loss was greater with both structured diets than with standard care

Greater weight loss was observed in iTRE and CR versus SC at month 2 and month 6. The Foodinnov summary of the trial reported that after six months participants in the intermittent-fasting group had lost about 7.4 kg, compared with about 7 kg in the calorie-restriction group, with both strategies producing significant loss compared with the control group. The Clinical Nutrition abstract reported greater weight loss in both structured-diet groups versus standard care at the same 2-month and 6-month points.

The trial therefore showed that both intermittent fasting and CR effectively induce weight loss when compared with guidelines-only care during the active intervention period. The authors’ stated conclusion was that both intermittent fasting and CR effectively induce weight loss, but they potentially act through distinct behavioural pathways. The mediation analysis was performed to examine the relationship between eating behaviour and weight loss at 2 and 6 months.

Calorie restriction increased dietary restraint more than fasting

Greater increases in dietary restraint were observed in CR versus iTRE and SC at month 2, 6 and 18. That difference persisted from the early intervention assessments through the 6-month assessment and remained present at the 18-month assessment. The Foodinnov report described the same pattern as a larger increase in cognitive dietary restraint in the classic-restriction group. The difference was observed even though weight loss at 2 and 6 months was greater with both iTRE and CR than with SC.

There was no detectable mediation effect of change in dietary restraint on weight loss. In other words, the larger rise in restraint in the CR group did not explain the weight-loss difference in the formal mediation test. The abstract reported the mediation examination for eating behaviour and weight loss at 2 and 6 months and found no detectable mediation through restraint change.

Reduced disinhibition explained part of the calorie-restriction effect

Greater reductions in disinhibition and feelings of hunger were also observed in CR versus iTRE and SC at month 6. The Foodinnov summary described the same result as a more marked decrease in disinhibition and in the sensation of hunger in the calorie-restriction group. The time point specified for that between-group difference in disinhibition and hunger was month 6.

Disinhibition appeared to mediate the effect on weight loss in CR, accounting for 15% of the total treatment effect. The Foodinnov report likewise stated that the decrease in dietary disinhibition explained about 15% of the weight loss observed in the calorie-restriction group. The authors interpreted this as indicating that improved control over eating played a role in the effectiveness of that approach. Their stated conclusion was that disinhibition plays a more prominent role in CR.

Fasting did not show the same behavioural shifts despite similar loss

Despite comparable weight loss, changes in eating behaviours were less marked in the fasting group. The Foodinnov summary stated that intermittent fasting did not appear to act through the same behavioural mechanisms as calorie restriction. It quoted the authors’ interpretation that the two strategies may rely on different psychological mechanisms.

The Clinical Nutrition conclusion likewise stated that intermittent fasting and CR potentially act through distinct behavioural pathways. The abstract reported greater restraint, disinhibition and hunger changes with CR, while reporting greater weight loss with both iTRE and CR versus SC. The pattern indicates similar scale outcomes through different measured behavioural routes during the period studied.

Mood, sleep, food addiction and quality of life showed no fasting disadvantage

The trial assessed mood, sleep and quality of life with validated questionnaires alongside eating behaviour. The Foodinnov summary stated that intermittent fasting did not worsen symptoms of depression or anxiety or sleep disturbances compared with calorie restriction. It also stated that the researchers did not observe an increase in food-addiction-type behaviours or binge-eating compulsions.

A slight increase in stress was observed after two months in the intermittent-fasting group, but that effect was no longer present after six months, according to the same Foodinnov report. The study aim described in that report was to assess whether intermittent fasting and calorie restriction acted differently on eating behaviour including hunger, restraint and disinhibition, mood including depression, anxiety and stress, sleep quality and participant quality of life. The questionnaires covered eating behaviour, hunger levels, disinhibition, anxiety, depression, stress, sleep and quality of life.

Support level and exclusions limit real-world reading

The participants were closely supervised, which may improve adherence and limit some negative effects seen under real-life conditions, according to the Foodinnov discussion of limitations. People with eating disorders had also been excluded from the trial. Those two points were presented as important limitations affecting interpretation outside the trial setting.

The difference in support was built into the design: both iTRE and CR groups received biweekly nutritional support, whereas SC received healthy guidelines at baseline only. Assessments extended to 18 months, beyond the 6-month active comparison, allowing the 18-month restraint finding to be reported. The 18-month difference in dietary restraint was a CR versus iTRE and SC difference.

What the 15% mediation finding means for counselling

The finding that disinhibition appeared to mediate the CR weight-loss effect and accounted for 15% of the total treatment effect points to control over eating in response to cues as one measured pathway. The Clinical Nutrition abstract presented disinhibition as more prominent in CR than the restraint pathway tested. The Foodinnov report expressed the same point as improved dietary control contributing to the effectiveness of the classic-restriction approach.

For intermittent fasting plus early time-restricted eating, the trial did not identify the same measured behavioural mediator despite greater weight loss than standard care. The Foodinnov summary stated that intermittent fasting could act through other mechanisms that remain poorly understood. The authors’ background statement was that these psychological and behavioural effects are poorly studied with intermittent fasting approaches.

Details for readers checking the source

The full paper reference is “Exploring the impact of intermittent fasting plus time-restricted eating versus calorie restriction on eating behavior, mood, sleep, quality of life in adults with obesity,” published in Clinical Nutrition on 15 May 2026, according to the Clinical Nutrition publication record. The identifier given is NCT03689608. The author list includes Xiao Tong Teong, Kai Liu, Andrew D. Vincent, Bo Liu, Gary Wittert, Amy T. Hutchison and colleagues.

The participant-level context and kilogram values in this article come from the Foodinnov trial summary, which described 209 adults with obesity, mean age 58, high type 2 diabetes risk, 7.4 kg loss with intermittent fasting and 7 kg with calorie restriction after six months, and the transient stress signal at two months. That summary also identified the journal as Clinical Nutrition and the publication date as 15 May 2026 and linked to the open-access article.